Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK

Hiroyuki Kobayashi1, Yusuke Narita, Motohiro Nishida

  • 1Department of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka 812-8582, Japan.

Cellular Signalling
|July 26, 2005
PubMed

Insights

Beta-arrestin2 enhances the nuclear localization of extracellular signal-regulated kinase (ERK) in beta-adrenergic receptor (betaAR) signaling. This beta-arrestin2-mediated mechanism is dependent on Gbetagamma and the beta2AR carboxyl-terminal region.

Area of Science:

  • Cellular signaling pathways
  • G protein-coupled receptor (GPCR) regulation
  • Molecular cell biology

Background:

  • Beta-arrestins are known to mediate the desensitization and internalization of beta-adrenergic receptors (betaARs).
  • Beta-arrestins also function as crucial scaffold proteins within the extracellular signal-regulated kinase (ERK) cascade.
  • The specific role of beta-arrestin2 in betaAR-mediated ERK signaling pathways requires further elucidation.

Purpose of the Study:

  • To investigate the role of beta-arrestin2 in beta-adrenergic receptor (betaAR)-mediated extracellular signal-regulated kinase (ERK) signaling.
  • To determine the specific mechanisms by which beta-arrestin2 influences ERK activation and localization.
  • To explore the involvement of Gbetagamma subunits and receptor structure in beta-arrestin2-mediated signaling.

Main Methods:

  • Utilized COS-7 cells co-expressing beta1AR or beta2AR with or without beta-arrestin2.
  • Stimulated cells with isoproterenol to activate betaARs.
  • Assessed cytoplasmic and nuclear ERK activation.
  • Employed pertussis toxin treatment and Gbetagamma blockade to investigate signaling pathways.
  • Generated chimeric receptors to examine the role of the carboxyl-terminal region.

Main Results:

  • Isoproterenol equally activated cytoplasmic and nuclear ERK in cells expressing beta1AR or beta2AR.
  • Co-expression of beta-arrestin2 significantly enhanced nuclear ERK activity in beta2AR-expressing cells, but not in beta1AR-expressing cells.
  • Pertussis toxin and Gbetagamma blockade inhibited beta-arrestin2-enhanced nuclear ERK activation, indicating a Gbetagamma-dependent mechanism.
  • A beta2AR mutant lacking the carboxyl-terminal region lost the beta-arrestin2-promoted nuclear translocation of ERK.

Conclusions:

  • Beta-arrestin2 plays a critical role in promoting the nuclear localization of ERK in response to beta2AR stimulation.
  • This nuclear translocation is dependent on Gbetagamma signaling and the specific recruitment of beta-arrestin2 to the beta2AR carboxyl-terminal region.
  • The findings highlight the distinct roles of beta-arrestin isoforms and receptor domains in regulating intracellular signaling cascades.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...